Patrick Frost, PhD

Patrick Frost, PhD

Jan 23, 2016

Group 6 Copy 32
1
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

How does Cotinine in cigarettes affect Vitamin-D concentration in women?

According to Lung Cancer Statistics from CDC, more people in the United States die from lung cancer than any...

Sex in the sea: Uncovering the mating behavior of Giant Sea Bass

I will be investigating the mating strategies and behavior of Giant Sea Bass. They have been largely overfished...

Backer Badge Funded